<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368248">
  <stage>Registered</stage>
  <submitdate>26/03/2015</submitdate>
  <approvaldate>9/04/2015</approvaldate>
  <actrnumber>ACTRN12615000322538</actrnumber>
  <trial_identification>
    <studytitle>Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol following intravenous and oral administration</studytitle>
    <scientifictitle>Plasma and cerebrospinal fluid concentrations of 1 g intravenous paracetamol compared with 1 g and 1.5 g oral paracetamol in adult surgical patients</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Analgesic concentrations of paracetamol</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Single bolus dose of 1 g intravenous paracetamol given immediately before induction of spinal anaesthesia</interventions>
    <comparator>Single bolus dose of 1 g oral paracetamol given immediately before induction of spinal anaesthesia (Arm 1) 

Single bolus dose of 1.5 g oral paracetamol given immediately before induction of spinal anaesthesia (Arm 2) </comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cerebrospinal fluid concentration of paracetamol</outcome>
      <timepoint>0, 15, 30, 45, 60, 90, 120, 180, 240 and 360 minutes following paracetamol administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Plasma concentration of paracetamol</outcome>
      <timepoint>0, 15, 30, 45, 60, 90, 120, 180, 240 and 360 minutes following paracetamol administration</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. aged 18 years and over
2. presenting for elective surgery under spinal anaesthesia
3. able to communicate in English
4. no contraindication to paracetamol
5. no paracetamol within previous 12 hours </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. aged &lt;18 years 
2. not planned for spinal anaesthesia
3. unable to communicate in English
4. contraindication to paracetamol
5. paracetamol within previous 12 hours </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients were approached by study staff before surgery and written informed consent was obtained. Randomisation occurred after consent was obtained. Randomisation results were concealed in sequentially numbered opaque envelopes. The appropriate envelope was opened just before paracetamol administration.</concealment>
    <sequence>The randomisation sequence was computer-generated. </sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>The scientist analysing the plasma and CSF samples was blind to group allocation.</designfeatures>
    <endpoint>Pharmacokinetics</endpoint>
    <statisticalmethods>The original intention was to use non-compartmental pharmacokinetic analysis techniques to address the study objectives, however, on completion of data collection and visualisation of the data, it was decided to employ population pharmacokinetic analysis techniques (i.e. nonlinear mixed-effects modelling).

The sample size for this trial was based upon the original primary endpoint of the maximum paracetamol concentration (Cmax) in CSF after IV or oral administration.  Using information published previously, it was determined that a sample size of 7 patients per group would be sufficient to detect a 2.8 fold difference in CSF Cmax between the IV and oral treatment groups with 80% power and a type I error rate of 5%.  </statisticalmethods>
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/02/2008</anticipatedstartdate>
    <actualstartdate>22/02/2008</actualstartdate>
    <anticipatedenddate>31/01/2009</anticipatedenddate>
    <actualenddate>16/03/2009</actualenddate>
    <samplesize>21</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Melbourne Hospital - City campus - Parkville</hospital>
    <postcode>3050 - Royal Melbourne Hospital</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Melbourne Hospital</primarysponsorname>
    <primarysponsoraddress>Grattan St, Parkville, VIC, 3050.</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital</fundingname>
      <fundingaddress>Grattan St, Parkville, VIC, 3050.</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study was to determine the concentrations of the drug paracetamol in the plasma and cerebrospinal fluid after intravenous and oral administration to adult patients having surgery under spinal anaesthesia.</summary>
    <trialwebsite />
    <publication>None yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Melbourne Health Human Research Ethics Committee</ethicname>
      <ethicaddress>Grattan St, Parkville, VIC, 3050.</ethicaddress>
      <ethicapprovaldate>5/12/2007</ethicapprovaldate>
      <hrec>2007.233</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Malcolm Hogg</name>
      <address>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Grattan St, Parkville, VIC, 3050</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>malcolm.hogg@mh.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Malcolm Hogg</name>
      <address>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Grattan St, Parkville, VIC, 3050</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>malcolm.hogg@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Malcolm Hogg</name>
      <address>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Grattan St, Parkville, VIC, 3050</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>malcolm.hogg@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, VIC, 3050</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>